Spots Global Cancer Trial Database for CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
Official Title: Clinical Trial for the Safety and Efficacy of CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
Study ID: NCT04662294
Interventions
Study Description
Brief Summary: A Study of CD 70 CAR T for patients with CD70 positive malignant hematologic diseases
Detailed Description: This is a single arm, open-label, single-center study. This study is indicated for CD 70 CAR T for patients with CD70 positive malignant hematologic diseases. The selections of dose levels and the number of subjects are based on clinical trials of similar foreign products. 108 patients will be enrolled. Primary objective is to explore the safety,main consideration is dose-related safety.
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The first affiliated hospital of medical college of zhejiang university, Hangzhou, Zhejiang, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
